Skip to main content

Catalyst Calendar

Mon, Sep 14, 2026

1 updates

7:00 AM

Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference

Presentation / Abstract • Phase 1Poster presentation Thu, Nov 12, 2026, 7:00 AM CETpasithea.com

Thu, Sep 3, 2026

1 updates

4:05 PM

Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences

pasithea.com

Tue, Jul 21, 2026

1 updates

7:00 AM

Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026

Presentation / Abstract • Phase 1ESMO poster presentation Fri, Oct 23, 2026, 3:15 PM CESTpasithea.com

Wed, Jul 8, 2026

1 updates

7:02 AM

Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit

pasithea.com

Tue, Jun 30, 2026

1 updates

7:00 AM

Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data Demonstrating Long-Term Safety and Tolerability, and Durable Clinical Activity in MEK/BRAF-Pretreated Patients, plus Protocol Expansion

Interim Data • Phase 1Interim data Tue, Jun 30, 2026pasithea.com